Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID

Corporate Breaking News

Home : Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID

Dec 21 2021	Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID
FRAUENFELD, Switzerland, Dec. 21, 2021 /PRNewswire/ -- "The use of ArtemiC Support has shown clear improvement of [long-COVID] symptoms after just a few days," states research collaborator Dr. Francisco Mera Cordero from the Catalan Health Authority DAP Costa de Ponent. COVID-19 is mainly...


Source:https://www.prnewswire.com:443/news-releases/swiss-pharmacans-supplement-authorized-for-immediate-clinical-study-to-confirm-effectiveness-against-long-covid-301448807.html

Related News
» Multichain (previously Anyswap) raises a $60M financing round led by Binance Labs » World Intelligent Vehicle Conference 2021 Helps Shape the Future of the Vehicle Industry